9,10-dimethyl-1,2-benzanthracene and Injuries, Radiation

9,10-dimethyl-1,2-benzanthracene has been researched along with Injuries, Radiation in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aromando, RF; Curotto, P; Garabalino, MA; Goldfinger, JA; Heber, EM; Hughes, AM; Itoiz, ME; Koivunoro, H; Nigg, DW; Palmieri, MA; Pozzi, EC; Ramos, P; Santa Cruz, IS; Schwint, AE; Thorp, S; Trivillin, VA	1
Chung, YL; Lee, MY; Pui, NN	1

Other Studies

2 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and Injuries, Radiation

Article	Year
Different oral cancer scenarios to personalize targeted therapy: Boron Neutron Capture Therapy translational studies. Therapeutic delivery, 2019, 06-01, Volume: 10, Issue:6 Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Boron Neutron Capture Therapy; Carcinogens; Cricetinae; Dose-Response Relationship, Radiation; Humans; Mouth Neoplasms; Mucositis; Neoplasms, Experimental; Radiation Injuries; Radiotherapy Dosage; Severity of Illness Index	2019
Epigenetic therapy using the histone deacetylase inhibitor for increasing therapeutic gain in oral cancer: prevention of radiation-induced oral mucositis and inhibition of chemical-induced oral carcinogenesis. Carcinogenesis, 2009, Volume: 30, Issue:8 Topics: 9,10-Dimethyl-1,2-benzanthracene; Acetylation; Administration, Oral; Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Transformation, Neoplastic; Cells, Cultured; Cricetinae; DNA Damage; DNA Repair; Enzyme Inhibitors; Fibroblasts; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Immunoenzyme Techniques; Male; Mesocricetus; Mouth Neoplasms; Phenylbutyrates; Rad51 Recombinase; Radiation Injuries; Radiation Tolerance; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stomatitis; Xenograft Model Antitumor Assays	2009

Article

Year

Different oral cancer scenarios to personalize targeted therapy: Boron Neutron Capture Therapy translational studies.

Therapeutic delivery, 2019, 06-01, Volume: 10, Issue:6

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Boron Neutron Capture Therapy; Carcinogens; Cricetinae; Dose-Response Relationship, Radiation; Humans; Mouth Neoplasms; Mucositis; Neoplasms, Experimental; Radiation Injuries; Radiotherapy Dosage; Severity of Illness Index

2019

Epigenetic therapy using the histone deacetylase inhibitor for increasing therapeutic gain in oral cancer: prevention of radiation-induced oral mucositis and inhibition of chemical-induced oral carcinogenesis.

Carcinogenesis, 2009, Volume: 30, Issue:8

Topics: 9,10-Dimethyl-1,2-benzanthracene; Acetylation; Administration, Oral; Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Transformation, Neoplastic; Cells, Cultured; Cricetinae; DNA Damage; DNA Repair; Enzyme Inhibitors; Fibroblasts; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Immunoenzyme Techniques; Male; Mesocricetus; Mouth Neoplasms; Phenylbutyrates; Rad51 Recombinase; Radiation Injuries; Radiation Tolerance; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stomatitis; Xenograft Model Antitumor Assays

2009